Young Women on Sexual and Reproductive Health Knowledge and Stigma Levels

October 25, 2023 updated by: Metin Yildiz, Sakarya University

The Effect of Education Given to Young Women on Sexual and Reproductive Health Knowledge and Stigma Levels: A Randomized Controlled Study

Aim: Failure to exercise reproductive and sexual rights can increase the risk of unwanted pregnancies, HIV and sexually transmitted infections, sexual coercion and violence, especially in young women. All of these situations affect the physical and mental health of young girls, as well as the health of their families.For this reason, The Effect of Education Given to Young Women on Sexual and Reproductive Health Knowledge and Stigma Levels: A Randomized Controlled Study was planned.

Material and method: The research was conducted as a randomized controlled experimental study. The universe of the research consisted of female students studying at the Faculty of Health Sciences of Ağrı İbrahim Çeçen University between January and June 2022. The sample consisted of individuals who were studying at the Faculty of Health Sciences of Ağrı İbrahim Çeçen University between the same dates and who met the inclusion criteria of the research. "Descriptive Feature Form", "Sexual and Reproductive Health Stigma Scale for Young Women" and sexual health knowledge test were used to collect data. In the analysis of data; percentile distribution, chi-square, Fisher-Freeman- Halton Exact test, paired samples test, t-test in independent groups, Friedman Test, One Way ANOVA test, and post hoc analyzes (Bonferroni, Games Howell, Dunn) were used.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Sakarya, Turkey, 54000
        • Sakarya University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 24 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria: Be between the ages of 18-24. Agree to participate voluntarily. -

Exclusion Criteria: be over 24 years old

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Group
Experimental: Intervention group
Face to face group
Face-to-face training was provided and supported by booklets.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Face to face group
Time Frame: 6 weeks
2. The Stigma of Sexual and Reproductive Health in Young Women Scale (SCASS): Hall et al. It was developed by in 2017 to identify the stigma of sexual and reproductive health in women aged 15-24. The original scale consists of 20 items and three sub-dimensions: Accepted stigma, Internalized Stigma, and Attitudes on which Stigma is Based. The accepted stigma sub-dimension consists of a total of 6 items. The lowest score that can be obtained from this dimension is 0, and the highest score is 7. The lowest score that can be obtained from the total of the scale is 0, and the highest score is 20. Each item of the scale is rated as 0=Disagree, 0=Neutral, 1=Agree. The higher the score, the higher the level of stigmatization. An increase in the score obtained from the scale indicates an increase in stigma. The Cronbach alpha value of the scale is 0.74. It is stated that the scale is suitable for all social classes.
6 weeks
Face to face group
Time Frame: 6 weeks
3. Sexual health knowledge test: It was developed by Petili and Gölbaşı in 2017, and its validity-reliability has been made. The test consists of 40 multiple-choice questions and includes 12 sub-dimensions. During the implementation of the CSBT, the participants are asked to carefully read each question and mark the answer they think is correct. Each answer marked correctly by the participant is scored as "1", and each answer marked incorrectly or left blank is scored as "0". The lowest score that can be obtained from CSBT is 0, and the highest score is 40. It is accepted that the higher the score, the higher the level of sexual health knowledge. The Cronbach alpha reliability coefficient of the test was found to be 0.88, and the internal consistency of the test was reported to be high reliability (Evcili & Gölbaşı, 2017)
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Metin YILDIZ, Asst.Prof.Dr., Sakarya University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2022

Primary Completion (Actual)

December 1, 2022

Study Completion (Actual)

January 25, 2023

Study Registration Dates

First Submitted

February 2, 2023

First Submitted That Met QC Criteria

March 3, 2023

First Posted (Actual)

March 15, 2023

Study Record Updates

Last Update Posted (Actual)

October 27, 2023

Last Update Submitted That Met QC Criteria

October 25, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SakaryaU-metinyildiz-004

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Inflammation

Clinical Trials on Face to face education

Subscribe